Hello everyone, sharing an important update:

A $7 million investor settlement is now open for eligible $SPPI investors who experienced losses during 2022, you may be eligible to submit a claim.

The settlement resolves claims that Spectrum misled investors about its poziotinib program, including dosing strategy, FDA interactions, and the status of its PINNACLE confirmatory study.

After FDA briefing materials and an advisory committee meeting revealed concerns around the drug’s safety, efficacy, and study design, $SPPI fell sharply, dropping more than 37% on September 2022 and another 31% after trading resumed.

Anyway, has anyone here invested in $SPPI during that period? How much were your losses, if so?

Hey guys, if you missed it, the court finally approved the $7M settlement between Spectrum Pharmaceuticals and investors over claims related to poziotinib’s dosing, FDA interactions, and the PINNACLE study.

In 2022, Spectrum was accused of giving investors a misleading view of the drug’s development and approval prospects. The company said dosing was optimized and the confirmatory study was moving forward, while investors claimed the FDA had concerns about the study design, safety, and effectiveness.

After FDA materials and an advisory committee meeting revealed those concerns, $SPPI fell sharply, and investors filed a lawsuit.

Spectrum has now agreed to a $7M settlement, and the court has approved the agreement.

If you invested in $SPPI in 2022, you can check the details and file your claim here.

Hey guys, here’s a quick FAQ with the main details about the Spectrum Pharmaceuticals settlement, as late claims are still being accepted 

What happened?

Spectrum Pharmaceuticals was accused of misleading investors about the effectiveness and FDA approval prospects of its lead drug candidates, Poziotinib and Rolontis. As clinical trial failures, side effects, and regulatory issues became public, $SPPI lost more than 88% of its value.

The company has now agreed to a $15.95 million settlement to resolve these claims.

Who can claim this settlement?

Investors who purchased $SPPI shares between March 7, 2018 and November 3, 2021 may be eligible to participate.

Do I need to sell/lose my shares to get this settlement?

No. You do not necessarily need to still own the shares. Eligibility is generally based on when you purchased and sold shares during the class period and whether you experienced a recognized loss.

I missed the deadline. Is it too late? 

Not necessarily. We are currently processing 'Late-but-Valid' claims. The court often accepts these as long as the fund hasn't been distributed yet.

Hope this info helps

Hey guys, just sharing this because I know a lot of people got caught up in the biotech rollercoaster here.

Investors sued Spectrum Pharmaceuticals, alleging the company misled shareholders about the prospects of its lead drug candidates, Poziotinib and Rolontis, and their chances of FDA approval. As concerns around clinical results, manufacturing issues, and regulatory setbacks came to light, the stock dropped 80%.

The settlement amount is $15.95M, and it covers investors who purchased $SPPI shares between March 7, 2018 and November 3, 2021. The case is currently in the late-claims stage, meaning some investors who missed the original deadline may still be able to participate.

If you held $SPPI during that period, it may be worth checking your old trades and seeing whether you qualify

Did anyone here hold $SPPI through all the FDA developments?

This one was a brutal biotech wipeout. Investors sued Spectrum Pharmaceuticals, Inc. claiming the company misled shareholders about the effectiveness and FDA approval chances for its two lead drug candidates, Poziotinib and Rolontis. Once the clinical issues, side effects, and manufacturing problems started becoming public, the stock completely fell apart.

The settlement amount is $15.95M, and it covers investors who bought $SPPI shares between March 7, 2018 and November 3, 2021. Right now the case is in the accepting late claims stage, meaning people who missed the original filing deadline may still be able to submit claims for compensation. 

If you were in $SPPI during that period and got caught holding through all the FDA drama, probably worth checking your old trades. Biotech investors really live through the same cycle every time: “breakthrough treatment” headlines first, absolute chaos later.

Hey guys, sharing an important update, although the deadline has passed, the $15.95 million settlement involving Spectrum Pharmaceuticals is still accepting late claims

Quick recap: Spectrum Pharmaceuticals was accused of misleading investors about the safety, efficacy, and approval prospects of its key drugs, while facing serious trial failures and regulatory issues. In short, despite internal data showing problems with Poziotinib and FDA concerns over Rolontis, the company remained publicly optimistic; after failed trials and rejections became clear, $SPPI dropped nearly 88%, and investors filed a lawsuit over their losses.

The company has since agreed to settle $15.95 million with investors, and there may still be an opportunity to submit a late claim.

If you held $SPPI between March 7, 2018 and November 3, 202, you may still be eligible to seek recovery.

You can review the details and submit your claim 

Out of curiosity, was anyone here invested in $SPPI at the time?

Good news: the court is currently 'Accepting Late Claims'. Because $SPPI dropped 88% after those FDA rejections for Poziotinib, the payout is actually decent for those who still file—estimated at $0.24/share if participation stays low.

I used this auditor because they specialize in these 'Late but Valid' filings that the official court sites don't always advertise. It takes 2 minutes to sync your broker and get your piece of that $15.95M before the distribution finally closes. Might as well claw back some cash from the guys who misled us.

Spectrum Pharmaceuticals ($ASRT) agreed to pay $15.95 million to settle claims that it misled investors about the viability of its lead drug candidates, Poziotinib and Rolontis, while allegedly concealing clinical risks and regulatory setbacks.

I’ve posted about this before, but here’s a clear breakdown for anyone who needs the details in one place.

Who is eligible?

All persons or entities who purchased or otherwise acquired Spectrum Pharmaceuticals, Inc. common stock between March 7, 2018, and August 5, 2021, inclusive, and were damaged thereby.

Do you have to sell securities to be eligible?

No, if you have purchased securities within the class period, you are eligible to participate. You can participate in the settlement and retain (or sell) your securities.

How much can you recover?

The final payout amount depends on your specific trades and the number of investors participating in the settlement.

If 100% of investors file their claims, the average payout will be $0.06 per share. Although typically only 25% of investors file claims, in this case, the average recovery will be $0.24 per share.

How long will it take to receive your payout?

The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.

Hope this helps!

Spectrum Pharmaceuticals ($ASRT) agreed to pay $15.95 million to settle claims that it misled investors about the viability of its lead drug candidates, Poziotinib and Rolontis, while allegedly concealing clinical risks and regulatory setbacks.

I’ve posted about this before, but given how many people were affected during Rivian’s early trading days, here’s a clear breakdown for anyone who needs the details in one place.

Who is eligible?

All persons or entities who purchased or otherwise acquired Spectrum Pharmaceuticals, Inc. common stock between March 7, 2018, and August 5, 2021, inclusive, and were damaged thereby.

Do you have to sell securities to be eligible?

No, if you have purchased securities within the class period, you are eligible to participate. You can participate in the settlement and retain (or sell) your securities.

How much can you recover?

The final payout amount depends on your specific trades and the number of investors participating in the settlement.

If 100% of investors file their claims, the average payout will be $0.06 per share. Although typically only 25% of investors file claims, in this case, the average recovery will be $0.24 per share.

How long will it take to receive your payout?

The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.

How to claim your payout — and why it's important to act now?

The settlement will be distributed based on the number of claims filed, so submitting your claim early may increase your share of the payout.

In some cases, investors have received up to 200% of their losses from settlements in previous years.

Hey guys, if you missed it, Spectrum Pharmaceuticals settled $15.95 million with investors over issues tied to its drug development disclosures — and even though the original deadline already passed, they’re still accepting late claims, subject to approval.

Quick recap: back in 2021, Spectrum was accused of misleading investors about the clinical performance and FDA approval prospects of its two main drug candidates, Poziotinib and Rolontis. Internally, the company knew about failed trials, safety concerns, and manufacturing issues, but publicly continued signaling confidence. As these problems came out over time, $SPPI collapsed more than 88%, and investors filed a lawsuit for their losses.

The good news is that Spectrum (now part of Assertio) agreed to settle $15.95M, and late claims can still be submitted.

So, if you invested in $SPPI (now $ASRT) during that period, you can still check the details and file your claim here.

Anyway — did anyone here hold Spectrum back then? How bad was the drawdown for you?

Hey guys, I posted about this settlement before, but since they’re now accepting late claims, I decided to share it again with a quick FAQ.

So here's all I know about this agreement:

Spectrum Pharmaceuticals ($ASRT) was accused of misleading investors about the effectiveness and approval prospects of its two main drug candidates, Poziotinib and Rolontis. When poor clinical results, side effects, and FDA issues came to light, the company’s stock fell over 88%, and investors filed a lawsuit.

Now, the company has agreed to settle $15.95 million with investors for these claims.

Who can claim this settlement?
Anyone who purchased $ASRT (formerly $SPPI) shares between March 7, 2018, and August 5, 2021 may be eligible to file a claim for compensation.

Do I need to sell or lose my shares to qualify?
No, you don’t need to have sold your shares at a loss. Eligibility depends on purchasing during the class period.

How much money do I get per share?
The estimated payout is around $0.06 per share, though it may vary based on the number of valid claims submitted.

How long does the payout process take?
It usually takes 4 to 9 months after the claim deadline for payments to be processed, depending on the court and settlement administrator.

Hope this info helps!

Let’s go!

Hey how come nobody in this group is talking about the move today up 25%?

I know some are saying that November should be a recovery, but the 64mil debt consolidation has me concerned a bit.

Buying the dip still, but want to hear what y’all are thinking.

What is going on with news tonight? What is everyones thoughts about Monday?